Thromboxane B2-d4
Thromboxane B2-D4 is the deuterium labeled Thromboxane B2. Thromboxane B2 is a prostaglandin derivative that is released during anaphylaxis. Thromboxane B2 induces arterial contraction and platelet aggregation[1][2].
Product Specifications
CAS Number
[1346112-79-5]
UNSPSC
12352005
Hazard Statement
H225, H319, H336
Target
Isotope-Labeled Compounds
Type
Isotope-Labeled Compounds
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Concentration
267.02 μM * 250 μL in Methyl acetate
Purity
99.9
Solubility
DMSO : ≥ 25 mg/mL
Smiles
O=C(O)CC([2H])([2H])C([2H])([2H])/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H](O)C[C@@H]1O
Molecular Formula
C20H30D4O6
Molecular Weight
374.51
Precautions
H225, H319, H336
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.
Shipping Conditions
Blue Ice
Storage Conditions
Solution, -20°C, 2 years
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MEF2B (Myocyte Enhancer Factor 2B, FLJ32599, FLJ46391, MGC189732, MGC189763, RSRFR2) (APC) discontinued
